-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Eloxx Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
- Eloxx Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$3.64M, a 49.1% increase year-over-year.
- Eloxx Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$19.3M, a 51.8% increase year-over-year.
- Eloxx Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$34.4M, a 47.9% increase from 2021.
- Eloxx Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$66M, a 97.3% decline from 2020.
- Eloxx Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$33.5M, a 33.8% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)